Privileged to present the LBBP-RESYNC pilot trial at the late breaking clinical trial session at #HRS2022 on behalf of Dr. Jiangang Zou. LBBP-RESYNC is the first RCT showing LBBP’s superior improvement of LVEF compared to BiV-CRT. Heart Rhythm Society

LBBP is a novel and revolutionary physiological pacing modality, which is expected to be the preferred strategy of resynchronization therapy for patients with heart failure and left bundle branch block.

Great China-US session hosted by legend Weijian Huang at the 6th Symposium of His-Purkinje Conduction System Pacing (HPCSP). Good to meet colleagues and exchange ideas: Jiangang Zou Keping Chen Yongmei Cha Gaurav A. Upadhyay Parikshit S Sharma, MD, MPH, FACC, FHRS @dontdisGD

Great to be finally back at #HRS2023 after three years, seeing old friends, meeting new ones and constant learning about the field. So privileged to be part of this fascinating field.